Krukenberg tumor |
Krukenberg Tumor
|
Classification and external resources |
ICD-10 |
C56 |
ICD-9 |
183 |
ICD-O |
8490/6 |
DiseasesDB |
30081 |
MeSH |
D007725 |
A Krukenberg tumor refers to a malignancy in the ovary that metastasized from a primary site, classically the gastrointestinal tract, although it can arise in other tissues such as the breast.[1] Gastric adenocarcinoma, especially at the pylorus, is the most common source.[2] Krukenberg tumors are often (over 80%)[2] found in both ovaries, consistent with its metastatic nature.[2]
Contents
- 1 Historical
- 2 Etiology and incidence
- 3 Symptoms
- 4 Pathogenesis
- 5 Treatment and prognosis
- 6 References
- 7 External links
Historical
Krukenberg tumors are named after Friedrich Ernst Krukenberg (1871–1946),[3] who reported what he thought was a new type of primary ovarian malignancy in 1896; six years later these were shown to be of metastatic gastrointestinal tract origin.[4] However, Paget had described the process in 1854.[4]
Etiology and incidence
Krukenberg tumors can be seen in all age groups, with an average age of 45 years.[2] In most countries, cancer that has metastasized to the ovary accounts for only about 1 to 2% of ovarian cancer;[2] in the remainder, the ovary itself is the primary cancer site. However, in Japan they represent a much higher percentage of malignancies in the ovary (almost 20%) due to the increased prevalence of gastric cancer.[2]
Krukenberg tumors account for about 15% of metastatic cancers that initially appear to have arisen in the ovary, and as such is less common than metastasis arising from ovarian epithelial and germ-cell tumors.[citation needed]
In people who have had nongynecologic malignancy, approximately 20% of adnexal masses are malignant, and 60% of these are Krukenberg tumors.[5]
Symptoms
Krukenberg tumors often come to the attention when they cause abdominal or pelvic pain, bloating, ascites, or pain during sexual intercourse. Krukenberg tumors can occasionally provoke a reaction of the ovarian stroma which leads to hormone production, that results in vaginal bleeding, a change in menstrual habits, or hirsutism,[6] or occasionally virilization[7] as a main symptom.
All these symptoms are non-specific and can also arise with a range of problems other than cancer, and a diagnosis can only be made following confirmatory investigations such as computed tomography (CT) scans, laparotomy and/or a biopsy of the ovary.
Pathogenesis
There has been debate over the exact mechanism of metastasis of the tumor cells from the stomach, appendix or colon to the ovaries. Classically it was thought that direct seeding across the abdominal cavity accounted for the spread of this tumor, but spread by way of the lymphatic is considered more likely.[2] The average age of diagnosis of Krukenberg tumors may partly relate to the relatively increased vascularity of the ovaries.[4]
Microscopically, Krukenberg tumors are often characterized by mucin-secreting signet-ring cells in the tissue of the ovary;[4] when the primary tumor is discovered, the same signet-ring cells are typically found. However, other microscopic features can predominate.[4][6] Krukenberg tumors are most commonly metastases from gastric cancer, particularly adenocarcinoma, or breast cancer[1] particularly invasive lobular breast carcinoma,[2] but they can arise in the appendix, colon, small intestine, rectum, gallbladder, and urinary bladder[6] or gallbladder, biliary tract, pancreas, ampulla of Vater or uterine cervix.[2]
Immunohistochemistry may help in diagnosing Krukenberg tumors from primary ovarian neoplasms[4] but needs to be applied with discretion.[8] For example, tumors that are immunoreactive to CEA or cytokeratin 20 (CK20) and negative for cytokeratin 7 (CK7) may be more likely to be of colorectal origin.[2]
Treatment and prognosis
Since Krukenberg tumors are secondary (metastatic), management might logically be driven by identifying and treating the primary cancer. The optimal treatment of Krukenberg tumors is unclear.[2] The role of surgical resection has not been adequately addressed[2] but if metastasis is limited to the ovaries, surgery may improve survival.[2][9][10] The role of chemotherapy and/or radiotherapy is uncertain[2] but may be sometimes be beneficial.[10]
References
- ^ a b Ackerman, Lauren Vedder; Rosai, Juan (2004). Rosai and Ackerman's surgical pathology 2. St. Louis: Mosby. p. 1708. ISBN 0-323-01342-2.
- ^ a b c d e f g h i j k l m n Al-Agha, O. M.; Nicastri, A. D. (2006). "An in-depth look at Krukenberg tumor: An overview". Archives of pathology & laboratory medicine 130 (11): 1725–1730. doi:10.1043/1543-2165(2006)130[1725:AILAKT]2.0.CO;2. ISSN 1543-2165. PMID 17076540. edit
- ^ Friedrich Ernst Krukenberg at Who Named It?
- ^ a b c d e f Young, R. H. (2006). "From Krukenberg to Today: The Ever Present Problems Posed by Metastatic Tumors in the Ovary". Advances in Anatomic Pathology 13 (5): 205–227. doi:10.1097/01.pap.0000213038.85704.e4. PMID 16998315. edit
- ^ Juretzka, M. M.; Crawford, C. L.; Lee, C.; Wilton, A.; Schuman, S.; Chi, D. S.; Sonoda, Y.; Barakat, R. R.; Abu-Rustum, N. R. (2006). "Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy". Gynecologic Oncology 101 (2): 327–330. doi:10.1016/j.ygyno.2005.10.025. PMID 16360202. edit
- ^ a b c Kiyokawa, T.; Young, R. H.; Scully, R. E. (2006). "Krukenberg tumors of the ovary: A clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations". The American journal of surgical pathology 30 (3): 277–299. doi:10.1097/01.pas.0000190787.85024.cb. PMID 16538048. edit
- ^ Papakonstantinou, E.; Liapis, A.; Kairi-Vassilatou, E.; Iavazzo, C.; Kleanthis, C. K.; Kondi-Pafiti, A. (2011). "Virilizing ovarian Krukenberg tumor in a 27-year-old pregnant woman. A case report and literature review". European journal of gynaecological oncology 32 (3): 331–333. PMID 21797128. edit
- ^ Young, R. H. (2007). "From Krukenberg to Today: The Ever Present Problems Posed by Metastatic Tumors in the Ovary. Part II". Advances in Anatomic Pathology 14 (3): 149–177. doi:10.1097/PAP.0b013e3180504abf. PMID 17452813. edit
- ^ Cheong, J. H.; Hyung, W. J.; Chen, J.; Kim, J.; Choi, S. H.; Noh, S. H. (2004). "Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer". Gynecologic Oncology 94 (2): 477–482. doi:10.1016/j.ygyno.2004.05.007. PMID 15297191. edit
- ^ a b Kim, W. Y.; Kim, T. J.; Kim, S. E.; Lee, J. W.; Lee, J. H.; Kim, B. G.; Bae, D. S. (2010). "The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries". European Journal of Obstetrics & Gynecology and Reproductive Biology 149 (1): 97–101. doi:10.1016/j.ejogrb.2009.11.011. PMID 20018420. edit
External links
Glandular and epithelial neoplasms (ICD-O 8010-8589)
|
|
Epithelium |
Papilloma/carcinoma
(8010-8139) |
- Small cell carcinoma
- Combined small cell carcinoma
- Verrucous carcinoma
- Squamous cell carcinoma
- Basal cell carcinoma
- Transitional cell carcinoma
- Inverted papilloma
|
|
|
Glands |
Adenomas/
adenocarcinomas
(8140-8429) |
Gastrointestinal |
- tract: Linitis plastica
- Familial adenomatous polyposis
- pancreas
- Insulinoma
- Glucagonoma
- Gastrinoma
- VIPoma
- Somatostatinoma
- Cholangiocarcinoma
- Klatskin tumor
- Hepatocellular adenoma/Hepatocellular carcinoma
|
|
Urogenital |
- Renal cell carcinoma
- Endometrioid tumor
- Renal oncocytoma
|
|
Endocrine |
- Prolactinoma
- Multiple endocrine neoplasia
- Adrenocortical adenoma/Adrenocortical carcinoma
- Hurthle cell
|
|
Other/multiple |
- Neuroendocrine tumor
- Adenoid cystic carcinoma
- Oncocytoma
- Clear cell adenocarcinoma
- Apudoma
- Cylindroma
- Papillary hidradenoma
|
|
|
Adnexal and
skin appendage (8390-8429) |
- sweat gland
- Syringocystadenoma papilliferum
|
|
Cystic, mucinous,
and serous (8440-8499) |
Cystic general |
- Cystadenoma/Cystadenocarcinoma
|
|
Mucinous |
- Signet ring cell carcinoma
- Mucinous cystadenoma / Mucinous cystadenocarcinoma
- Mucoepidermoid carcinoma
|
|
Serous |
- Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous cystadenocarcinoma
|
|
|
Ductal, lobular,
and medullary (8500-8549) |
Ductal carcinoma |
- Mammary ductal carcinoma
- Pancreatic ductal carcinoma
- Comedocarcinoma
- Paget's disease of the breast / Extramammary Paget's disease
|
|
Lobular carcinoma |
- Lobular carcinoma in situ
- Invasive lobular carcinoma
|
|
Medullary carcinoma |
- Medullary carcinoma of the breast
- Medullary thyroid cancer
|
|
|
Acinar cell (8550-8559) |
|
|
|
Other |
Complex epithelial (8560-8589) |
|
|
|
- See also
- Template:Epithelium and epithelial tissue
|
|
Tumors: female urogenital neoplasia (C51–C58/D25–D28, 179–184/218–221)
|
|
Adnexa |
Ovaries |
Glandular and epithelial/
surface epithelial-
stromal tumor |
CMS: |
- Ovarian serous cystadenoma
- Mucinous cystadenoma
- Cystadenocarcinoma
- Papillary serous cystadenocarcinoma
- Krukenberg tumor
|
|
- Endometrioid tumor
- Clear-cell ovarian carcinoma
- Brenner tumour
|
|
|
Sex cord-gonadal stromal |
- Leydig cell tumour
- Sertoli cell tumour
- Sertoli-Leydig cell tumour
- Thecoma
- Granulosa cell tumour
- Luteoma
- Sex cord tumour with annular tubules
- Steroid cell tumor (NOS)
|
|
Germ cell |
- Dysgerminoma
- Nongerminomatous
- Embryonal carcinoma
- Endodermal sinus tumor
- Gonadoblastoma
- Teratoma/Struma ovarii
- Choriocarcinoma
|
|
Fibroma |
|
|
|
Fallopian tube |
|
|
|
Uterus |
Myometrium |
- Uterine fibroids/leiomyoma
- Leiomyosarcoma
- Adenomyoma
|
|
Endometrium |
- Endometrioid tumor
- Uterine papillary serous carcinoma
- Clear cell carcinoma
- Endometrial intraepithelial neoplasia
|
|
Cervix |
- Cervical intraepithelial neoplasia
- SCC
- Glassy cell carcinoma
- Villoglandular adenocarcinoma
|
|
Placenta |
- Choriocarcinoma
- Gestational trophoblastic disease
|
|
General |
- Uterine sarcoma
- Mixed Müllerian tumor
|
|
|
Vagina |
- SCC
- Botryoid rhabdomyosarcoma
- Clear cell adenocarcinoma of the vagina
- Vaginal intraepithelial neoplasia
|
|
Vulva |
- SCC
- Melanoma
- Papillary hidradenoma
- Extramammary Paget's disease
- Vulvar intraepithelial neoplasia
|
|
Index of reproductive medicine
|
|
Description |
- Anatomy
- Physiology
- Development
- sex determination and differentiation
|
|
Disease |
- Infections
- Congenital
- Neoplasms and cancer
- male
- female
- gonadal
- germ cell
- Other
- Symptoms and signs
|
|
Treatment |
- Procedures
- Drugs
- benign prostatic hypertrophy
- erectile dysfunction and premature ejaculation
- sexual dysfunction
- infection
- hormones
- androgens
- estrogens
- progestogens
- GnRH
- prolactin
- Assisted reproduction
- Birth control
|
|
|
Digestive system neoplasia (C15–C26/D12–D13, 150–159/211)
|
|
GI tract |
Upper |
Esophagus |
- Squamous cell carcinoma
- Adenocarcinoma
|
|
Stomach |
- Gastric carcinoma
- Signet ring cell carcinoma
- Gastric lymphoma
- Linitis plastica
|
|
|
Lower |
Small intestine |
|
|
Appendix |
- Carcinoid
- Pseudomyxoma peritonei
|
|
Colon/rectum |
- colorectal polyp: Peutz–Jeghers syndrome
- Juvenile polyposis syndrome
- Familial adenomatous polyposis/Gardner's syndrome
- Cronkhite–Canada syndrome
- neoplasm: Adenocarcinoma
- Familial adenomatous polyposis
- Hereditary nonpolyposis colorectal cancer
|
|
Anus |
|
|
|
Upper and/or lower |
- Gastrointestinal stromal tumor
- Krukenberg tumor (metastatic)
|
|
|
Accessory |
Liver |
- malignant: Hepatocellular carcinoma
- Hepatoblastoma
- benign: Hepatocellular adenoma
- Cavernous hemangioma
- hyperplasia: Focal nodular hyperplasia
- Nodular regenerative hyperplasia
|
|
Biliary tract |
- bile duct: Cholangiocarcinoma
- Klatskin tumor
- gallbladder: Gallbladder cancer
|
|
Pancreas |
- exocrine pancreas: Adenocarcinoma
- Pancreatic ductal carcinoma
- cystic neoplasms: Serous microcystic adenoma
- Intraductal papillary mucinous neoplasm
- Mucinous cystic neoplasm
- Solid pseudopapillary neoplasm
|
|
|
Peritoneum |
- Primary peritoneal carcinoma
- Peritoneal mesothelioma
- Desmoplastic small round cell tumor
|
|
Index of digestion
|
|
Description |
- Anatomy
- Physiology
- Development
|
|
Disease |
- Congenital
- Neoplasms and cancer
- Inflammatory bowel disease
- Gluten sensitivity
- Other
- Symptoms and signs
- Blood tests
|
|
Treatment |
- Procedures
- Drugs
- anabolic steroids
- antacids
- diarrhoea and infection
- bile and liver
- functional gastrointestinal disorders
- laxatives
- peptic ulcer and reflux
- nausea and vomiting
- other
- Surgery
|
|
|